DEK is a mammalian protein that has been implicated in the pathogenesis of autoimmune diseases and cancer, including acute myeloid leukemia, melanoma, glioblastoma, hepatocellular carcinoma, and bladder cancer. In addition, DEK appears to participate in multiple cellular processes, including transcriptional repression, mRNA processing, and chromatin remodeling. Sub-nuclear distribution of this protein, with the attendant functional ramifications, has remained a controversial topic. Here we report that DEK undergoes acetylation in vivo at lysine residues within the first 70 N-terminal amino acids. Acetylation of DEK decreases its affinity for DNA elements within the promoter, which is consistent with the involvement of DEK in transcriptional repression. Furthermore, deacetylase inhibition results in accumulation of DEK within interchromatin granule clusters (IGCs), sub-nuclear structures that contain RNA processing factors. Overexpression of P/CAF acetylase drives DEK into IGCs, and addition of a newly developed, synthetic, cellpermeable P/CAF inhibitor blocks this movement. To our knowledge, this is the first reported example of acetylation playing a direct role in relocation of a protein to IGCs, and this may explain how DEK can function in multiple pathways that take place in distinct sub-nuclear compartments. These findings also suggest that DEK-associated malignancies and autoimmune diseases might be amenable to treatment with agents that alter acetylation.The mammalian nuclear protein DEK is associated with the pathogenesis of autoimmune diseases and cancer (1-3).Autoantibodies specific for DEK are present in patients with juvenile rheumatoid arthritis and other inflammatory diseases (4, 5), and fusion of dek and can by translocation of chromosomes 6 and 9 results in acute myeloid leukemia (6). DEK expression is also increased in multiple malignancies, including bladder cancer, hepatocellular carcinoma, glioblastoma, melanoma, T-cell large granular lymphocyte leukemia, and acute myeloid leukemia, independent of the t(6,9) chromosomal translocation (1, 2, 7-9). Indeed, a gene profile analysis of 41 adult patients with acute myeloid leukemia using quantitative real-time PCR showed that DEK is overexpressed in 98% of the cases (10). Most recently, quantitative multiplex PCR was used to precisely map the focal region of genomic gain on chromosome 6p22 in bladder cancer cells (7). Genomic mapping data identified the dek gene as being centrally located within this minimal region, suggesting DEK as an important candidate for involvement in pathogenesis of bladder cancer.DEK does not belong to any characterized protein family, and sequence similarity with other factors is limited to the SAF (scaffold attachment factor) box (11, 12), also known as the SAP domain (from SAF-A/B, acinus and PIAS) (13), a 34-amino acid motif found in nuclear factors that participates in chromatin organization, mRNA processing, and transcription. Interestingly, DEK has been implicated in all three of these nuclear events. We have previou...